Neurocrine Biosciences, Inc. (NBIX)
135.30
-0.27
(-0.20%)
USD |
NASDAQ |
Jan 09, 13:16
Neurocrine Biosciences Research and Development Expense (Annual): 707.60M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Masimo Corp. | 222.80M |
| Insulet Corp. | 219.60M |
| Marker Therapeutics, Inc. | 13.47M |
| CapsoVision, Inc. | 15.12M |